Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Xian-Jun Yu, M.D PH.D
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center,sun Yat-Sen University
Guangzhou, Guangdong, China
Sheng-Ping Li, M.D PH.DRecruiting - Department of Biliary Pancreatic Surgery, Huadong Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Wei Wang, M.D PH.DRecruiting - Department of Biliary Pancreatic Surgery, Shanghai Changzheng Hospital, the Second Military Medical University
Shanghai, Shanghai Municipality, China
Cheng-Hao Shao, M.D PH.DRecruiting - Department of Pancreatic Surgery, Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
De-Liang Fu, M.D PH.DRecruiting - Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality, China
Xianjun Yu, M.D., Ph.D.Recruiting - Department of Pancreatic Surgery, Cancer Institute & Hospital, Tianjin Medical University
Tianjin, Tianjin Municipality, China
Ji-Hui Hao, M.D PH.DRecruiting - Department of General Surgery,sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Yi-Ping Mou, M.D PH.DRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 31 Dec 2018
- Completion
- 30 Jun 2019
- Last update posted
- 11 Aug 2016
- Registered enrollment
- 300
- Registry id
- NCT02506842
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.